Microvascular Alterations in Alzheimer's Disease.

Area of Science:

• Neuroscience
• Neurology
• Pathology

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder causing progressive cognitive decline.
• Amyloid beta (Aβ) has been a primary therapeutic target, but treatments focusing on Aβ removal have shown limited success.
• Emerging research suggests other factors like tau pathology, neuroinflammation, and vascular dysfunction contribute significantly to AD pathogenesis.

Purpose of the Study:

• To review the current state of Alzheimer's disease research.
• To examine research directions beyond amyloid beta, including tau, inflammation, and protein clearance.
• To highlight the role of aging and microvascular changes in AD and discuss potential therapeutic avenues.

Main Methods:

• Review of existing Alzheimer's disease research literature.
• Analysis of studies focusing on tau pathology, neuroinflammation, and protein clearance mechanisms.
• Examination of imaging studies investigating microvascular alterations and capillary function in AD.

Main Results:

• Traditional amyloid beta-centric approaches have not led to significant cognitive improvements or cures.
• Aging-associated microvascular changes, including reduced cerebral blood flow, impair cognition in AD.
• Microvascular dysfunction, evidenced by capillary malfunction, is a notable feature in Alzheimer's disease.

Conclusions:

• Future Alzheimer's disease therapies may need to address multiple pathological pathways beyond amyloid beta.
• Protecting brain tissue through vascular recovery and modulating neuroinflammation shows promise.
• Targeting growth factors for vascular repair and inhibiting specific ion channels to reduce microglial activation are potential therapeutic strategies.